Dhaakirah Yakubu

Targeting Alzheimer’s disease pathways with Caralluma dalzielii: behavioural, biochemical, and molecular evidence from a transgenic Drosophila melanogaster model

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with limited disease-modifying therapies, necessitating the exploration of novel therapeutic agents. Caralluma dalzielii, a medicinal plant traditionally used for neurological disorders, has not previously been...